date,headline,sentiment
2009-08-17 12:14:00+00:00,"BenchmarkJournal.com Free Analyst Review for ABK, EQR, KMB, BBD, FIG and MRK",neutral
2009-09-18 07:38:00+00:00,Sanofi-aventis (SNY) Completes Acquisition of Merial ,neutral
2009-11-04 20:38:00+00:00,"Fitch Downgrades Merck, Outlook Stable",mildly bearish
2009-11-04 21:02:00+00:00,Merck Says It Won't Seek Another Larger Merger,mildly bullish
2009-11-13 16:32:00+00:00,Merck (MRK) Drugs Under Scanner Of Cholesterol Study,neutral
2009-11-16 11:22:00+00:00,JPMorgan Likes Abbott (ABT) Because of Niaspan,neutral
2010-01-08 19:22:00+00:00,"Investment Mantra 2010: Be Bullish On Mega Caps In ‘The Dogs Of The Dow’. (XOM, WFC, BA, CVX, DU, MCD, MRK, PFE) ",mildly bullish
2010-01-14 14:22:00+00:00,"Stock Market News for January 14, 2010 - Market News",neutral
2010-02-10 20:10:00+00:00,Merck & Co. (MRK) Agrees To Changes In Vioxx Settlement,neutral
2010-03-08 14:01:00+00:00,Simple Quantitative View of Goldman's VIP List Generates Some Other Long Ideas,neutral
2010-04-05 11:33:00+00:00,"U.S. Equity Market Preview (AAPL, EXC, HSP, ITMN, MRK)",neutral
2010-05-12 10:27:00+00:00,"US Stocks End Lower Yesterday After Soaring On Monday, Dow And S&P Down, Nasdaq Bucks Trend",mildly bearish
2010-05-20 15:15:00+00:00,"All 30 Dow Components In The Red (MRK, GE)",mildly bearish
2010-05-27 15:29:00+00:00,"Deutsche Bank Sees A Brighter Future for Drug Stocks (MRK, PFE)",mildly bullish
2010-06-29 20:42:00+00:00,Good News for NVO's Victoza - Analyst Blog,mildly bullish
2010-07-07 20:29:00+00:00,Puts Purchased on Millipore Corp. (MIL),neutral
2010-07-27 13:15:00+00:00,Sanofi-aventis and Merck Appoint CEO for Joint Venture,neutral
2010-07-28 22:39:00+00:00,Fast Money 360: Leerink Swann Is A Buyer Of Merck (MRK),mildly bullish
2010-07-30 18:11:00+00:00,Hapoalim Securities Downgrades Merck to Hold from Buy (MRK),mildly bearish
2010-08-04 14:26:00+00:00,"Zacks Analyst Blog Highlights: The Clorox, AstraZeneca, Merck, Dean Foods and Coach - Press Releases",neutral
2010-08-09 21:52:00+00:00,Cost Reduction Lowers ENZN Loss - Analyst Blog,mildly bullish
2010-08-26 13:32:00+00:00,A New Round Of Corporate Layoffs?,mildly bearish
2010-08-30 15:20:00+00:00,Goldman Sachs Introduces And Adjusts Estimates For Major Pharmaceuticals,neutral
2010-09-13 20:36:00+00:00,SurModics Stays Neutral - Analyst Blog,neutral
2010-09-21 12:04:00+00:00,"Zacks Analyst Blog Highlights: ProShares UltraShort 20+ Year ETF, Pfizer, Merck, Ford and CarMax  - Press Releases",neutral
2010-10-12 18:22:00+00:00,Highest Yielding Dow Jones Industrial Average Stocks,neutral
2010-10-25 11:39:00+00:00,Citi Says Merger Should Help Merck (MRK),mildly bullish
2010-10-29 09:46:00+00:00,"Earnings Scheduled For October 29 (CVX, POM, CEG, MRK, PGN, NEE, SNE, D, EL, ITT, CI, WY, EIX, LNT)",neutral
2010-10-29 13:03:00+00:00,"Merck Beats on EPS, Misses on Revs - Analyst Blog",mildly bearish
2010-10-30 01:14:00+00:00,"Steve Grasso's Health Care Trades (UNH, CI, AET, AGP, HS, PFE, MRK, WLP)",neutral
2010-11-17 16:03:00+00:00,"Merck Adding To Its List Of Late stage Revenue Generating Assets, Citigroup Reports",mildly bullish
2010-11-22 13:29:00+00:00,Goldman Sachs Comments On Merck's SHARP Results,mildly bullish
2010-11-24 09:11:00+00:00,"Stock Market News for November 24, 2010 - Market News",neutral
2010-11-30 09:28:00+00:00,Merck Halts Isentress Study - Analyst Blog,mildly bearish
2010-12-01 13:58:00+00:00,SurModics Cut to Underperform - Analyst Blog,mildly bearish
2010-12-02 09:26:00+00:00,Merck May Buy Biotech Firm SmartCells,mildly bullish
2010-12-06 16:20:00+00:00,Change at Pfizer's Helm - Analyst Blog,neutral
2010-12-15 18:03:00+00:00,CPI: Inflation Still Tame - Analyst Blog,neutral
2010-12-30 19:23:00+00:00,"XOMA Shares Climb 8.6% (XOMA, NVG, MRK)",neutral
2011-01-14 12:19:00+00:00,Jefferies Cuts Price Target On Merck (MRK),mildly bearish
2011-01-17 14:13:00+00:00,"Company News for January 17, 2011 - Corporate Summary",neutral
2011-01-21 12:10:00+00:00,Deutsche Bank Lowers PT On Merck & Co.,mildly bearish
2011-01-21 12:42:00+00:00,"Deutsche Bank Lowers MRK Target To $43, Reiterates Buy Rating",mildly bullish
2011-01-28 18:12:00+00:00,AstraZeneca Revenues Disappoint - Analyst Blog,neutral
2011-02-03 17:48:00+00:00,Merck Beats but Guides Lower - Analyst Blog,mildly bearish
2011-03-16 19:59:00+00:00,"Some High Dividend Paying Stocks For A Weak Market (MO, MRK, JNJ, NLY)",neutral
2011-03-25 11:33:00+00:00,"Citi Comments On MRK's Return Of Betrixaban, Maintains EPS Estimate",neutral
2011-04-25 12:35:00+00:00,"Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing   ",mildly bullish
2011-04-27 11:45:00+00:00,Merck Announces New $5 Billion Share Repurchase Program (MRK),mildly bullish
2011-04-27 12:00:00+00:00,Deutsche Bank To Hold 36th Annual Healthcare Conference Next Week,neutral
2011-04-27 20:54:00+00:00,VICTRELIS™ Unanimously Recommended for Approval by FDA Advisory Committee (MRK),mildly bullish
2011-04-29 10:21:00+00:00,"US Stock Futures Mixed As Investors Await Economic Data, Earnings Reports; Research In Motion Shares Decline In Pre-Market trading",neutral
2011-04-29 22:35:00+00:00,Royal Put(z) Not to Be Confused with Married Put(z)  04-29-2011,neutral
2011-05-16 11:31:00+00:00,Bank Of America Raises PT To $29 On MRK,mildly bullish
2011-05-16 12:16:00+00:00,Deutsche Bank Comments on Victrelis FDA Approval,neutral
2011-05-17 15:30:00+00:00,Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C ,mildly bullish
2011-06-03 13:26:00+00:00,"Pimco's Gross Likes P&G and Merck, Offer Better Yields and Conservative -Bloomberg",mildly bullish
2011-06-09 16:22:00+00:00,5-Alpha Reductase Inhibitors May Increase Risk of Prostate Cancer -FDA,mildly bearish
2011-07-07 13:16:00+00:00,Goldman Sachs Suggests Buying Calls on Merck & Co.,mildly bullish
2011-07-18 12:06:00+00:00,Merck's ISENTRESS in Combination Therapy Demonstrated Efficacy in a Phase II Study Extending to Nearly Five Years in Previously Untreated Adults with HIV-1 ,mildly bullish
2011-07-19 14:14:00+00:00,Dow Jones Industrial Average Companies Increase Expected Dividend Distribution by 12.66% From a Year Ago,mildly bullish
2011-07-29 11:02:00+00:00,Merck Guides FY 2011 EPS $3.68-$3.76 vs $3.74 Est,mildly bearish
2011-07-29 20:16:00+00:00,5 Stocks You Can Buy for Less Than Bill Gates Paid,mildly bullish
2011-08-02 19:53:00+00:00,"Aw Snap, Is Market Gonna Crackle or Pop?",neutral
2011-08-30 11:03:00+00:00,Merck Millipore Strengthens Bioscience Business by acquiring Amnis Corporation,mildly bullish
2011-09-08 03:25:00+00:00,Stocks Going Ex Dividend the Third Week of September,neutral
2011-09-13 22:30:00+00:00,Merck Issues Statement on HPV Vaccine,neutral
2011-09-28 20:10:00+00:00,Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals for $175M   ,mildly bullish
2011-09-30 14:55:00+00:00,Merck Announces New Data Analyses for VICTRELIS will be Presented at The American Association for the Study of Liver Diseases 2011 Annual Meeting   ,neutral
2011-10-28 07:33:00+00:00,Earnings Scheduled For October 28,neutral
2012-01-03 14:30:00+00:00,Merck & Hits 52-Week High of $37.98,mildly bullish
2012-01-04 18:40:00+00:00,Bark At The Dow's Dogs With These ETFs,neutral
2012-01-18 23:53:00+00:00,"Benzinga's M&A Chatter for Wednesday January 18, 2012",neutral
2012-01-20 16:00:00+00:00,What's the Future Like For Health Care?,neutral
2012-01-25 13:34:00+00:00,UPDATE: Merck: FDA Did Not Approve New Indication For Vytorin Because of Study Design,mildly bearish
2012-01-26 01:04:00+00:00,"Benzinga's M&A Chatter for Wednesday January 25, 2012",neutral
2012-02-13 15:15:00+00:00,"FDA Approves ZIOPTAN, Merck's Once-Daily, Preservative-Free Ophthalmic Medication",mildly bullish
2012-03-07 12:26:00+00:00,From Earlier: Merck Announces Results from Investigational Studies with VICTRELIS Presented at the Conference on Retroviruses and Opportunistic Infections to Understand Potential Use in Patients Coinfected with Chronic Hepatitis C and HIV-1  ,neutral
2012-03-12 22:39:00+00:00,"Benzinga's M&A Chatter for  Monday March 12, 2012",neutral
2012-03-26 14:09:00+00:00,Merck Reports C$35M Investment and Start of Merck Lumira Fund,mildly bullish
2012-03-27 15:25:00+00:00,"Merck Spokesperson, Responding to Chatter of $26 Offer for Amarin, Says Company Policy is Not to Respond to Rumors Regarding Business Development Deals",neutral
2012-03-27 23:50:00+00:00,"Benzinga's M&A Chatter for Tuesday March 27, 2012",neutral
2012-04-03 22:47:00+00:00,Merck,neutral
2012-04-16 11:30:00+00:00,Endocyte Resumes Trading,neutral
2012-04-19 11:00:00+00:00,Merck Reports Phase III Study Results Evaluating Anaemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy   ,neutral
2012-04-22 15:23:00+00:00,"Earnings Expectations for the Week of April 23 (AAPL, XOM, UPS)",neutral
2012-04-30 19:43:00+00:00,New Kids: Do These New ETFs Have The Right Stuff?,neutral
2012-05-15 18:31:00+00:00,"S&P Bullish On Biotech ETFs (FBT, IBB, XBI)",mildly bullish
2012-05-31 12:49:00+00:00,Merck CEO Says He Isn't Interested in Breaking Up the Company -Bloomberg,neutral
2012-06-05 20:37:00+00:00,"Merck Gets Response Letter for Ridaforolimus, Says Added Clinical Trials Would Need to be Conducted; In Talks with EU Health Authorities -Bloomberg",neutral
2012-06-14 12:25:00+00:00,Johnson & Johnson to Complete Synthes Acquisition ,neutral
2012-06-26 15:57:00+00:00,Amylin Pharmaceuticals Spiking to Highs on Earlier Bid Reports,neutral
2012-06-26 17:17:00+00:00,Spokesperson for Amylin Pharmaceuticals Won't Comment on Rumor of Bids from Pharma Companies,neutral
2012-06-29 16:51:00+00:00,ALPS Unveils Dogs of the Dow ETF,neutral
2012-07-10 20:05:00+00:00,"Deutsche Bank Maintains Merck & at Buy, Raises PT from $43 to $47.25",mildly bullish
2012-07-12 09:52:00+00:00,"Citigroup Upgrades Merck & from Neutral to Buy, Raises PT from $34 to $50",mildly bullish
2012-07-12 14:48:00+00:00,UPDATE: Citigroup Upgrades Merck; Raises PT,mildly bullish
2012-07-17 15:38:00+00:00,Merck Says Court Approves Proposed Erisa Settlement,neutral
2012-07-27 11:01:00+00:00,Merck & Reports Q2 EPS $1.05 vs $1.01 Est; Revenues $12.2B vs $12.15B Est,mildly bullish
2012-08-24 11:13:00+00:00,"Bank of America Downgrades Merck & from Buy to Neutral, Announces PO of $45",mildly bearish
2012-08-24 16:05:00+00:00,"UPDATE: Bank of America Merrill Lynch Downgrades Merck to Neutral, Reiterates $45 PT",mildly bearish
2012-10-09 12:10:00+00:00,Merck to Move Global Headquarters Within New Jersey  ,neutral
2012-10-13 19:27:00+00:00,Merck BMD Data from a Phase II Study of Odanacatib Shows Significantly Increased Bone Mineral Density,mildly bullish
2012-10-15 10:16:00+00:00,"AiCuris, Merck Enter Exclusive Worldwide License Agreement ",mildly bullish
2012-10-15 16:12:00+00:00,"Barclays Maintains Merck & at Overweight, Raises PT from $46 to $50",mildly bullish
2012-11-14 13:58:00+00:00,These ETFs Offer Solid Yield in Uncertain Times,mildly bullish
2012-11-20 17:11:00+00:00,"MKM Partners Upgrades Merck & from Neutral to Buy, Raises PT from $47 to $51",mildly bullish
2012-12-11 22:23:00+00:00,"Benzinga's M&A Chatter for Tuesday December 11, 2012",neutral
2012-12-18 12:31:00+00:00,"Merck, GE Healthcare Announce Collaboration on Use of Imaging Biomarkers for Investigational BACE Inhibitor Program",mildly bullish
2013-01-02 21:47:00+00:00,"Merck Says FDA Acknowledged Resubmission of NDA for Ezetimibe, Atorvastatin Tablets",neutral
2013-01-07 13:01:00+00:00,Merck Receives FDA Acceptance of Resubmission of NDA for Sugammadex Sodium Injection,mildly bullish
2013-02-05 12:41:00+00:00,"Merck Serono, Opexa Therapeutics Enter Option, License Agreement for Development of Tcelna",mildly bullish
2013-03-04 11:23:00+00:00,"Bank of America Upgrades Merck & Company, Inc. to Buy, Maintains $47.00 PO",mildly bullish
2013-03-04 12:10:00+00:00,UPDATE: Bank of America Upgrades Merck to Buy; Pullback Creates Meaningful Upside Potential,mildly bullish
2013-03-25 12:53:00+00:00,"Bank of America Reiterates Buy Rating, $47 PT on Merck & Co. Ahead of Potential Approvals",mildly bullish
2013-04-10 12:04:00+00:00,"Jefferies Maintains Hold on Merck & Company, Inc., Raises PT to $48.00",mildly bullish
2013-04-10 16:11:00+00:00,UPDATE: Jefferies Raises PT on Merck & Co. on Positive Outlook,mildly bullish
2013-04-11 15:21:00+00:00,"Court Says Merck Victory Upholding Vytorin Patents Will Stand, Says Mylan Can't Sell Copies of Vytorin, Zetia Before Apr. 2017",mildly bullish
2013-05-01 11:04:00+00:00,"Merck & Company, Inc. Reports Q1 EPS of $0.85 vs $0.79 Est; Revenue of $10.70B vs $11.09B Est",mildly bearish
2013-05-01 11:14:00+00:00,Merck Announces New $15B Buyback Plan,mildly bullish
2013-05-22 11:36:00+00:00,Merck FDA Advisory Committee Meeting for Insomnia Drug Suvorexant Begins at 8 AM ET,neutral
2013-05-22 20:17:00+00:00,FDA Panel Votes 13-3 Merck's Suvorexant is Safe in Low Doses,mildly bullish
2013-05-28 14:50:00+00:00,"UPDATE: Jefferies Upgrades Merck to Buy, Raises PT Following SOTP Analysis",mildly bullish
2013-06-03 12:10:00+00:00,Benzinga's Top Pre-Market Gainers,neutral
2013-06-10 15:40:00+00:00,Merck Loses US Appeal of Apotex Patent Win Over Nasonex,mildly bearish
2013-07-01 21:05:00+00:00,FDA Approves New U.S. Labeling for ISENTRESS® (raltegravir) to Include 240-Week Results from STARTMRK Study of ISENTRESS Containing Regimen in Previously Untreated HIV-1 Infected Adult Patients ,mildly bullish
2013-07-16 15:30:00+00:00,Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY),neutral
2013-07-26 13:15:00+00:00,"Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin ",neutral
2013-07-31 10:33:00+00:00,"Benzinga Market Primer: Wednesday, July 31: Futures Higher Heading Into FOMC Decision",neutral
2013-07-31 10:41:00+00:00,Bionomics Signs Option and License Agreement With Merck ,mildly bullish
2013-08-14 15:08:00+00:00,"13F from Leon Cooperman's Omega Advisors Shows New Stakes in Thermo-Fisher, McKesson, Liquidated Stakes in Freeport-McMoRan, Facebook, Covidien, Raised Stakes in DISH, Citi, Lowered Stakes in Merck, AIG, Polycom",mildly bearish
2013-09-04 19:56:00+00:00,Merck's Durham Site Receives US FDA License for Varicella Bulk,mildly bullish
2013-10-01 11:32:00+00:00,"Merck Cutting 8,500 Jobs Related to Global Initiative to 'Sharpen Commercial, R&D Focus,' Sees Pretax Charge $2.5-3B, Reaffirms FY13 Outlook",mildly bearish
2013-10-01 12:30:00+00:00,"Merck Says Will Close Summit Campus, Will Move Global HQ to Kenilworth",neutral
2013-10-01 17:03:00+00:00,Merck Says Interim Data for MK-3475 to be Presented at 15th World Conference on Lung Cancer,mildly bullish
2013-10-07 12:12:00+00:00,Merck Says Data Shows Cognigram as Sensitive Assessment,mildly bullish
2013-10-08 20:57:00+00:00,"Credit Suisse Starts Pfizer, Bristol-Myers, AbbVie, Allergan at Outperform, Merck, Eli Lilly, Forest Labs at Neutral",neutral
2013-10-14 10:52:00+00:00,"Bernstein Downgrades Merck & Company, Inc. to Market Perform, Lowers PT to $50.00",mildly bearish
2013-10-14 11:46:00+00:00,Benzinga's Top Downgrades,neutral
2013-10-24 14:28:00+00:00,"Merck Says Primary Endpoints Met for Investigational 9-Valent HPV Vaccine, Expecting to Submit BLA for V503 in 2013",mildly bullish
2013-10-24 14:28:00+00:00,"Merck Says Primary Endpoints Met for Investigational 9-Valent HPV Vaccine, Expecting to Submit BLA for V503 in 2013",mildly bullish
2013-10-25 20:18:00+00:00,Benzinga Weekly Preview: FOMC Meeting Closely Watched,neutral
2013-10-28 09:27:00+00:00,"Stocks To Watch For October 28, 2013",neutral
2013-12-10 12:10:00+00:00,Merck Says Data Monitoring Committee Recommending Continuation of Phase II/III EPOCH Study for MK-8931,mildly bullish
2014-01-27 21:48:00+00:00,"Market Wrap For January 27: China Concerns, Declining Home Sales, Tomorrow's Fed Meeting and Obama's Speech Keep Markets Lower",mildly bearish
2014-02-04 12:50:00+00:00,"SunTrust Robinson Humphrey Upgrades Merck & Company, Inc. to Buy",mildly bullish
2014-02-05 12:14:00+00:00,"Merck & Company, Inc. Sees FY2014 EPS $3.35-3.53 vs $3.47 Est; Sees Sales $42.40B-43.20B vs $43.54B Est",mildly bearish
2014-03-03 15:39:00+00:00,The Top Five Dow Stocks In February,mildly bullish
2014-03-14 17:43:00+00:00,FDA Approves Merck Noxafi Injection for Intravenous Use ,mildly bullish
2014-03-21 12:07:00+00:00,"Merck, Endocyte Announce European CHMP Positive Opinions for VYNFINIT, Companion Agents FOLCEPRI, NEOCEPRI",mildly bullish
2014-03-21 12:17:00+00:00,Benzinga's Top #PreMarket Gainers,neutral
2014-04-29 19:41:00+00:00,"Bids for Merck Consumer-Health Unit Said to Be Over $14B, Bayer Looking to Weigh JV with Merck as Part of Offer - Bloomberg",mildly bullish
2014-05-02 15:05:00+00:00,#Premarket Preo Technical Update - Merck Trading Lower,mildly bearish
2014-05-16 12:03:00+00:00,"Chimerix Announces Has Regained Worldwide Rights to CMX157 from Merck, Says Co. Will No Longer Pursue Development",mildly bearish
2014-05-19 21:01:00+00:00,"Merck, Endocyte Report Withrdrawal of Conditional Marketing Authorization for Vintafolide, Companion Imaging from EMA",strongly bearish
2014-05-23 18:19:00+00:00,#Premarket Technical Update - Merck Trading Higher,mildly bullish
2014-05-30 13:20:00+00:00,"Merck Announces Generic Name for MK-3475, Pembrolizumab",neutral
2014-06-04 18:08:00+00:00,ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy,neutral
2014-06-06 15:44:00+00:00,#Premarket Prep Technical Update - Merck Trading Lower,mildly bearish
2014-06-12 11:59:00+00:00,UPDATE: Bank Of America Reiterates On Merck & Co. On Higher Sales Estimates,mildly bullish
2014-06-12 15:23:00+00:00,"UPDATE: Merck Research Head Says Company Aims to Capture Big Share of Hep C Market, Selling Best Drugs at Fair Cost",mildly bullish
2014-06-30 12:02:00+00:00,Merck Announces Investigational Data From Phase 3 Emend,mildly bullish
2014-07-07 20:37:00+00:00,Markets Marginally Lower Ahead Of Earnings Season,neutral
2014-07-29 15:00:00+00:00,Markets Open Higher; Merck Posts Upbeat Profit,mildly bullish
2014-07-29 18:27:00+00:00,#Premarket Prep Technical Update - Merck Trading Higher,mildly bullish
2014-09-26 18:26:00+00:00,"Fast Money Halftime Report Final Trade From September 26 - Merck & Co., Inc., NCR Corporation And BP plc",neutral
2014-10-03 18:27:00+00:00,#Premarket Prep Technical Update - Merck Trading Higher,mildly bullish
2014-10-06 09:18:00+00:00,Merck Commences Public Debt Offering ,neutral
2014-10-08 18:40:00+00:00,#Premarket Prep Technical Update - Merck Trading Sharply Higher,mildly bullish
2014-10-26 20:55:00+00:00,"Earnings Expectations For The Week Of October 27: Facebook, Exxon, Pfizer And Much More",neutral
2014-10-27 09:06:00+00:00,"Earnings Scheduled For October 27, 2014",neutral
2014-10-27 16:41:00+00:00,Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip,neutral
2014-10-27 19:34:00+00:00,Merck Conference Call Highlights,neutral
2014-10-28 12:00:00+00:00,"#PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Progress On Ebola",neutral
2014-11-10 00:04:00+00:00,Interim Data from C-SWIFT Study of Merck's Investigational Hepatitis C Treatment Grazoprevir/Elbasvir in Combination with a Nucleotide Inhibitor Presented at The Liver Meeting,mildly bullish
2014-11-24 12:30:00+00:00,"Merck, NewLink Genetics Report Entering of Licensing, Collaboration Deal for Investigational Ebola Vaccine",mildly bullish
2014-12-06 04:14:00+00:00,Merck in Talks to Acquire Cubist Pharmaceuticals for More Than $7B; Could be Announced as Early as Next Week -NYT Dealbook,mildly bullish
2014-12-06 04:24:00+00:00,Merck in Talks to Acquire Cubist for ~$100/Share,mildly bullish
2014-12-07 23:24:00+00:00,Benzinga's Weekend M&A Chatter,neutral
2014-12-08 15:20:00+00:00,Benzinga's Volume Movers,neutral
2014-12-08 22:43:00+00:00,3 Biotech ETFs Rally On Merger News,mildly bullish
2014-12-09 20:02:00+00:00,Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO,neutral
2014-12-19 13:01:00+00:00,Merck Begins Tender Offer To Acquire Cubist,mildly bullish
2014-12-22 19:11:00+00:00,#Premarket Prep Technical Update - Merck Lower,mildly bearish
2014-12-23 20:22:00+00:00,"FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities",neutral
2015-01-15 11:26:00+00:00,Fast Money Halftime Report Final Trade From January 14,neutral
2015-01-29 16:56:00+00:00,#Premarket Prep Technical Update - Merck Lower,mildly bearish
2015-01-29 16:56:00+00:00,#Premarket Prep Technical Update - Merck Lower,mildly bearish
2015-02-04 10:13:00+00:00,"Earning & Economic Calendar for Wednesday February 4, 2015",neutral
2015-02-04 12:05:00+00:00,"Merck Sees FY15 Adj. EPS $3.32-$3.47 Including Items, Sales $38.3B-$39.8B Including Items",mildly bullish
2015-02-04 13:03:00+00:00,"UPDATE: Merck Posts Upbeat Q4 Earnings, Sales Decline",mildly bullish
2015-02-06 00:58:00+00:00,Merck Prices $8B Debt Offering,neutral
2015-02-06 20:28:00+00:00,"After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?",neutral
2015-02-19 13:41:00+00:00,NewLink Genetics Announces $20M Milestone Payment From MERCK,mildly bullish
2015-02-23 12:06:00+00:00,UPDATE: Merck to Make Upfront Payment  NGM of $94M; Acquire 15% Stake in NGM for $106M,mildly bullish
2015-02-24 09:43:00+00:00,Merck Collaborates with Medicines Patent Pool to Expand Access to Pediatric Formulations of Raltegravir in Developing Countries,mildly bullish
2015-03-13 20:02:00+00:00,Merck Provides Regulatory Update On Sugammadex Injection,neutral
2015-03-16 19:35:00+00:00,Merck Announced Results From Investigational IMPROVE-IT Study That Shows VYTORIN Reduced Total Cardiovascular Events By 9% Vs. SIMVASTATIN,mildly bullish
2015-04-08 11:04:00+00:00,"Grazoprevir/Elbasvir, Merck's Investigational Chronic Hepatitis C Therapy, Granted FDA Breakthrough Therapy Designations; New Phase 2, 3 Data in Multiple HCV Patient Types Will Be Presented At The International Liver Congress TM 2015",mildly bullish
2015-04-17 20:31:00+00:00,It's A Big Weekend For Biotech,neutral
2015-04-20 12:05:00+00:00,"Tetralogic Announces Co., Merck Will Collaborate Related to Evaluation of Birinapant In Combo With KEYTRUDA in Solid Tumors",mildly bullish
2015-04-22 16:54:00+00:00,"Goat Plague (PPR) Affecting Herds in Africa, Asia -Reuters",neutral
2015-04-28 11:03:00+00:00,"Merck Raises FY15 Adj. EPS Outlook from $3.32-$3.47 Previously to $3.35-$3.48 vs $3.37 Est., Affirms Sales Outlook",mildly bullish
2015-04-28 13:30:00+00:00,Bank Of America On Merck: 'MAGNIF-TECOS!',mildly bullish
2015-04-28 13:45:00+00:00,Morning Market Gainers,neutral
2015-05-22 17:57:00+00:00,Expert Explains How To Play Merck In 2 Charts,neutral
2015-05-29 12:31:00+00:00,"Amgen, Merck Report Expansion of Collaboration to Support Studies of Talimogene Laherparepvec in Combo with KEYTRUDA in Patients with Head and Neck Cancer",mildly bullish
2015-06-08 16:10:00+00:00,UPDATE: Celgene Shares at High Following Early Rumored Bid from Merck,mildly bullish
2015-06-09 00:17:00+00:00,"Benzinga's M&A Chatter for  Monday June 8, 2015",neutral
2015-06-10 12:46:00+00:00,"Merck, Samsung Bioepis Report Pivotal Phase 3 Studies for Investigational Biosimilars SB4, Enbrel (Etanercept), and SB2, Remicade (Infliximab), Met Primary Endpoints",mildly bullish
2015-06-16 13:55:00+00:00,Hearing Merck Approached Dublin Based Alkermes With $12.4B Offer-Market Sources,mildly bullish
2015-06-17 20:13:00+00:00,Hearing Dept. of Justice Has Said Merck's Inspire Pharma to Pay $5.9M to Settle Civil Claims of Fraud,mildly bearish
2015-06-29 12:31:00+00:00,Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint,mildly bullish
2015-07-06 16:16:00+00:00,9 Top Sell Ideas From Oppenheimer's Technical Analysis Division,neutral
2015-07-09 12:56:00+00:00,"Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz",mildly bullish
2015-08-13 10:35:00+00:00,"BMO Capital Upgrades Merck & Co to Outperform, Raises PT to $70.00",mildly bullish
2015-08-13 13:13:00+00:00,Benzinga's Top Upgrades,neutral
2015-08-13 13:14:00+00:00,Good Data May Be Coming For Merck (And This Analyst Is Bullish),mildly bullish
2015-08-24 16:57:00+00:00,Sierra Leone Released its Last Confirmed Ebola Patient from Hospital on Monday -Reuters,neutral
2015-08-31 00:37:00+00:00,Barron's Recap: What's Next?,neutral
2015-09-01 13:06:00+00:00,New Analyses from the IMPROVE-IT Study with VYTORIN (ezetimibe and simvastatin),neutral
2015-09-01 18:40:00+00:00,"Hearing Buyside Volume Coming Into Staples, Drug, And Chemical Names",mildly bullish
2015-09-08 11:59:00+00:00,MKM Partners Would Sell These Healthcare Stocks On Weaker Relative Trends,mildly bearish
2015-09-18 15:00:00+00:00,"Eli Lilly's 'Home Run' Is Jardiance, Says Morgan Stanley",mildly bullish
2015-10-02 17:44:00+00:00,FDA Approves Merck's Keytruda For Advanced Non-Small Cell Lung Cancer,mildly bullish
2015-11-03 11:58:00+00:00,"GSK, Merck to Study Immunotherapy Combination as Potential Cancer Treatment",mildly bullish
2015-11-05 13:43:00+00:00,Merck Announces Samsung Bioepis Will Present New Biosimilars Data at the 2015 ACR/ARHP Annual Meeting,neutral
2015-11-18 12:00:00+00:00,"Merck, Darmstadt, Pfizer Report FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma",mildly bullish
2015-11-22 01:55:00+00:00,Merck Announces Initial Results for KEYTRUDA with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress,mildly bullish
2015-11-24 09:26:00+00:00,15-Year Old Boy is First Ebola Fatality in Liberia Since Country was Declared Ebola Free in September -Reuters,strongly bearish
2015-11-30 14:01:00+00:00,"Deere Announces Factory Workforce Adjustments, 220 Employees On Indefinite Leave Starting Feb 2016",neutral
2015-12-21 18:43:00+00:00,Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average,mildly bullish
2016-01-06 12:53:00+00:00,Washington University Initiates Clinical Study of Verastem's VS-6063 in Combination with Merck's Pembrolizumab and Gemcitabine in Pancreatic Cancer,mildly bullish
2016-01-06 17:51:00+00:00,Why This Codexis Analyst Is Confident Stock Is Worth $6,mildly bullish
2016-01-12 12:14:00+00:00,Fast Money Traders Share Their Biotech Picks,neutral
2016-01-13 09:27:00+00:00,WHO to Announce End of Ebola Outbreak on Thursday -AFP,mildly bullish
2016-01-14 21:19:00+00:00,Sierra Leone Health Ministry Investigating Suspected Death from Ebola -Reuters,mildly bearish
2016-01-25 16:16:00+00:00,US Big Pharma: What To Watch For In Q4 Results,neutral
2016-01-28 16:48:00+00:00,Adam Feurestein Reminds Twitter Followers 'Today Is Merck's HepC elbasvir/grazoprevir PDUFA',neutral
2016-01-29 15:14:00+00:00,From Conf Call: Abbvie Says Merck's New Hep C Drug Will Crimp Viekira Pak Sales,mildly bearish
2016-02-02 09:21:00+00:00,"Sanofi, Merck Considering Ending JV to Sell Vaccines in Europe -Bloomberg",neutral
2016-02-02 15:18:00+00:00,"Merck, Sanofi Exploring Potential End To Joint Venture In Europe",neutral
2016-02-03 13:42:00+00:00,Shares Of Merck Dip Lower Following Q4 Print,mildly bearish
2016-02-24 15:05:00+00:00,AureoGen Announces Licensing Agreement with Merck,mildly bullish
2016-03-10 21:46:00+00:00,"The Stocks That Moved The S&P, Dow And Nasdaq Today",neutral
2016-03-12 17:04:00+00:00,Agenus Shares Spike Higher Following Mid-Day Upgrade To Buy From Maxim,mildly bullish
2016-04-12 13:25:00+00:00,"Notable Imbalances Before Tuesday's Open Led By Under Armour, Boeing, Caterpillar",neutral
2016-04-13 08:20:00+00:00,Merck Announces License Application for Investigational House Dust Mite SLIT-tablet Accepted for Review by FDA,mildly bullish
2016-04-13 11:00:00+00:00,"FDA Accepts Supplemental Biologics License Application for Merck's KEYTRUDA in Recurrent or Metastatic Head and Neck Cancer, and Grants Priority Review",mildly bullish
2016-05-05 08:36:00+00:00,"Earnings Scheduled For May 5, 2016",neutral
2016-05-27 11:48:00+00:00,Merck Receives Positive CHMP Opinion for ZEPATIER in the European Union,mildly bullish
2016-05-27 12:38:00+00:00,Merck Gets Favorable Opinion From CHMP For Its ZEPATIER,mildly bullish
2016-06-03 17:49:00+00:00,"Ouch! Jobs Report Miss Sends Rate Hike Odds Down, Raises Questions",mildly bearish
2016-06-06 13:09:00+00:00,"Merck, Pfizer Offers Results from Pivotal Avelumab Study",mildly bullish
2016-06-07 12:47:00+00:00,FDA Staff Has Said Overall Clinical Results from Merck's Bezlotoxumab Trial Could Negatively Impact Cure Rate of Initial Episode of Infection with C. Difficile,mildly bearish
2016-06-09 13:52:00+00:00,"Hearing Merck May Be Interested In RLYP, Unconfirmed Takeover Chatter",mildly bullish
2016-06-09 21:07:00+00:00,Merck To Acquire Afferent Pharmaceuticals,mildly bullish
2016-06-16 17:10:00+00:00,Cramer Talks About Merck's 'Fabulous News' And Why The Market Can't Rally,mildly bullish
2016-06-27 12:41:00+00:00,Merck Gets CHMP Positive Opinion For KEYTRUDA For Advanced Non-Small Cell Lung Cancer Treatment,mildly bullish
2016-07-18 10:29:00+00:00,BMO Capital Downgrades Merck & Co to Market Perform,mildly bearish
2016-07-21 21:00:00+00:00,"Merck Animal Health Receives FDA Approval of BRAVECTO For Cats And Dogs, Topical Treatment for Fleas and Ticks Effective for up to 12 Weeks",mildly bullish
2016-07-22 16:08:00+00:00,Merck Presents Data On Its Investigational Once-Daily Formulation Of ISENTRESS,mildly bullish
2016-07-25 12:05:00+00:00,"NewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA, PRIME Status from EMA for Investigational Ebola Zaire Vaccine",mildly bullish
2016-08-02 23:35:00+00:00,"Benzinga's M&A Chatter for Tuesday August 2, 2016",neutral
2016-08-04 00:26:00+00:00,"Benzinga's M&A Chatter for Wednesday August 3, 2016",neutral
2016-08-05 12:23:00+00:00,Merck Spike in Price Likely Attributed to Negative Results on Bristol-Myers' Opdivo,mildly bearish
2016-08-05 13:03:00+00:00,Bristol's Opdivo Misses Endpoint In Late-Stage Trial; Merck Rallies Sharply Amid Keytruda Potential,mildly bullish
2016-08-08 11:36:00+00:00,Citi Doesn't See Merck's Lung Cancer Success Lasting Long,mildly bearish
2016-08-08 13:58:00+00:00,8 Biggest Price Target Changes For Monday,neutral
2016-08-08 21:05:00+00:00,Results from Merck's Phase 3 Study Of Zepatier Hep C Treatment Published In Annals Of Internal Medicine,mildly bullish
2016-08-17 16:55:00+00:00,"UPDATE: Reuters Says Merck, Sanofi, Pfizer, Gilead, Celgene Have Each Submitted Expressions of Interest for Medivation",mildly bullish
2016-08-31 14:16:00+00:00,"Shares Of Celgene Spiking Higher, Hearing Unconfirmed Rumors That Big Restructuring Under Way & Speculation Is That They Are Prepping Deal With Merck",mildly bullish
2016-10-09 12:19:00+00:00,Merck Presents Longer-Term Follow-Up of Overall Survival Data for KEYTRUDA in Patients with Advanced Melanoma from KEYNOTE-002 at ESMO 2016,mildly bullish
2016-10-09 12:27:00+00:00,Merck Announces KEYTRUDA Showed Continued Overall Survival Benefit Compared to Chemotherapy with Longer Follow-Up in Patients with Previously Treated Metastatic NSCLC in Data to Be Presented at ESMO 2016,mildly bullish
2016-10-13 11:49:00+00:00,A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Jobless Claims Report,mildly bearish
2016-10-13 13:58:00+00:00,7 Biggest Price Target Changes For Thursday,neutral
2016-10-19 16:38:00+00:00,"Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage",neutral
2016-10-25 18:26:00+00:00,Technical Alert: Merck Higher After Q3 Report,mildly bullish
2016-11-03 15:19:00+00:00,BZ NOTE Related to Traders Passing Around CNBC Story on New Cancer Drugs Possibly Damaging the Heart: NBC News via AP Published the Same Story ~7 p.m. EDT Wed. Evening,neutral
2016-12-05 14:34:00+00:00,"Biothera, Merck Further Expand Research Collaboration to Include Phase 2 Clinical Trial in Head and Neck Cancer",mildly bullish
2017-01-10 22:12:00+00:00,Bristol-Myers Shares Down 2.2% After Hours as Merck Shares Trade Up ~2.5% Following News KEYTRUDA Accepted for Supplemental BLA,mildly bullish
2017-01-12 15:11:00+00:00,Favorable News On Keytruda Drives Piper Jaffray's Upgrade Of Merck,mildly bullish
2017-01-20 11:52:00+00:00,Wall Street's M&A Chatter From January 19,neutral
2017-01-20 21:02:00+00:00,"Merck Announces Setlement With Bristol-Myers Resolving KEYTRUDA Patent Litigation, Will Pay $625M And Provide Royalties On KEYTRUDA In Any Market In Which It's Approved",mildly bullish
2017-01-27 19:29:00+00:00,"Andrew Left Furthers Comments Following ESRX Release Today, Points To Comment Made By Merck President Of U.S. Commercial To Highlight Thesis That Drug Co.'s Offer Incentives To PBM's To Stay On Preferred Drug Lists",mildly bearish
2017-02-02 11:46:00+00:00,"Merck Sees FY17 Adj. EPS $3.72-$3.87 vs $3.85 Est., Sales $38.6B-$40.1B vs $40B Est.",mildly bearish
2017-02-23 19:06:00+00:00,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market',mildly bullish
2017-03-06 13:02:00+00:00,"Merck, Pfizer Report U.S. FDA and EMA Filing Acceptances of 3 Marketing Applications for Ertugliflozin-Containing Medicines For Adult Type 2 Diabetes Patients",mildly bullish
2017-03-08 19:22:00+00:00,Everything We Know About Merck's Keytruda,neutral
2017-03-14 19:24:00+00:00,FDA Has Approved Merck's Keytruda For Intravenous Use In Hodgkin Lymphoma,mildly bullish
2017-04-07 11:30:00+00:00,Merck Reports Received CRL from FDA Related to TECOS Study with Sitagliptin,neutral
2017-04-21 12:03:00+00:00,Atara Bio Partners With Merck To Evaluate KEYTRUDA In Combination With ATA129 In NPC,mildly bullish
2017-05-02 10:48:00+00:00,"Merck Q1 EPS $0.88 vs $0.83 Est, Sales $9.43B vs $9.25B Est",mildly bullish
2017-05-19 12:00:00+00:00,Merck Reports Received CHMP Opinion Recommending Approval of ISENTRESS 600 mg in EU,mildly bullish
2017-05-29 18:54:00+00:00,Congo Approves Use of Merck Ebola Vaccine -DJ,mildly bullish
2017-06-04 21:41:00+00:00,Merck Announces Presentation of New Monotherapy Data for KEYTRUDA in Heavily Pre-Treated Patients with Advanced Gastric Cancer#ASCO17,mildly bullish
2017-06-29 20:13:00+00:00,Aduro Biotech Initiates Phase 2 Clinical Trial Of CRS-207 In Combination With KEYTRUDA,mildly bullish
2017-06-30 20:10:00+00:00,Benzinga's Option Alert Recap From June 30,neutral
2017-07-13 18:43:00+00:00,"Shares of Eli Lilly, AstraZeneca, Merck, Gilead, Abbvie, Other Large Cap Biotech Spiking Higher",mildly bullish
2017-07-24 11:10:00+00:00,"Merck Gives Results from ONCEMRK, A Study of ISENTRESS HD",neutral
2017-07-27 07:41:00+00:00,"AstraZeneca, Merck Announce Strategic Oncology Collaboration; Merck to pay AstraZeneca up to $8.5B in Total Consideration",mildly bullish
2017-07-28 08:17:00+00:00,"Earnings Scheduled For July 28, 2017",neutral
2017-07-28 08:35:00+00:00,"10 Stocks To Watch For July 28, 2017",neutral
2017-07-28 10:46:00+00:00,UPDATE: Merck Raises FY17 Adj. EPS Outlook From $3.72-$3.87 To $3.76-$3.88 vs $3.85 Est.,mildly bullish
2017-08-07 11:11:00+00:00,"Merck Animal Health to Acquire Austrian Manufacturing Facility, Terms Not Disclosed",neutral
2017-08-14 12:51:00+00:00,CNBC Now Tweets: JUST IN: Merck CEO resigns from Trump's manufacturing council amid fallout from the President's comments.,neutral
2017-08-14 15:31:00+00:00,Doug Kass Tweets: I am buying $MRK just on principle.  @maddow @MSNBC @carlquintanilla @jimcramer @tomkeene @andrewrsorkin @BeckyQuick,mildly bullish
2017-08-15 12:34:00+00:00,The Market In 5 Minutes,neutral
2017-08-24 17:46:00+00:00,"Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva",mildly bullish
2017-08-31 14:52:00+00:00,"Merck Shares Move To Session Lows, Up 0.4% For Session, As Traders Circulating FDA.gov Alert 'FDA Alerts Healthcare Professionals and Oncology Clinical Investigators about Two Clinical Trials on Hold Evaluating KEYTRUDA® in Patients w/ MM'",mildly bearish
2017-09-07 11:19:00+00:00,"Wall Street's M&A Chatter From September 6: Cabelas, Merck-Rigontec, Altice-Charter, Amazon-Kohl's",neutral
2017-09-08 12:02:00+00:00,Merck Reports Updated Data For KEYTRUDA In Patients With Advanced Gastric Cancer Across Treatment Settings,mildly bullish
2017-09-09 14:41:00+00:00,"Incyte, Merck Announce Positive Progression-Free Survival Data from ECHO-202 Trial of Epacadostat in Combination with KEYTRUDA in Patients with Advanced Melanoma at ESMO 2017",mildly bullish
2017-09-11 13:15:00+00:00,"Morgan Stanley Healthcare Conference Begins Today, Presenters Include: Veeva Systems, Quorum Health, Neurocrine Biosciences, Vertex Pharma, Merck, Ocular Therapeutix, Biogen, Gilead, and Bristol-Myers",neutral
2017-10-13 13:58:00+00:00,Bank Of America Sees NewLink Genetics As 'Undervalued',mildly bullish
2017-10-20 15:35:00+00:00,"Fierce Pharma Reports Merck Lays Off 1,800 U.S. Sales Reps To Overhaul Primary Care Marketing",mildly bearish
2017-10-24 16:35:00+00:00,Healthcare ETFs Set To Soar As Q3 Earnings Unfold,mildly bullish
2017-10-27 08:36:00+00:00,"12 Stocks To Watch For October 27, 2017",neutral
2017-10-30 10:40:00+00:00,Morgan Stanley Downgrades Merck & Co to Equal-Weight,mildly bearish
2017-10-30 13:22:00+00:00,"Benzinga's Top Upgrades, Downgrades For October 30, 2017",neutral
2017-10-30 16:30:00+00:00,35 Stocks Moving In Monday's Mid-Day Session,neutral
2017-10-31 08:54:00+00:00,40 Biggest Movers From Yesterday,neutral
2017-11-06 17:19:00+00:00,"Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",neutral
2017-11-24 15:00:00+00:00,5 Biggest Price Target Changes For Friday,neutral
2017-11-28 19:33:00+00:00,Merck Reports $10B Buyback Plan,mildly bullish
2018-01-08 11:32:00+00:00,Merck Announces FDA Accepts NDA For Doravirine,mildly bullish
2018-01-19 11:30:00+00:00,Merck Reports LYNPARZA For Treatment Of Advanced Ovarian Cancer Received Approval In Japan,mildly bullish
2018-01-19 11:45:00+00:00,"Merck Reports First-Time Data For KEYTRUDA In Patients With Previously-Treated Advanced HCC: 'showed an overall response rate (ORR) of 16.3 percent (95% CI, 9.8-24.9) (n=17/104) with KEYTRUDA as monotherapy'",mildly bullish
2018-01-23 15:58:00+00:00,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,mildly bullish
2018-02-15 11:38:00+00:00,"Merck Reports Co., AstraZeneca Won Orphan Drug Designation By FDA For Selumetinib For Treatment Of NF1",mildly bullish
2018-02-23 12:30:00+00:00,"Merck, AstraZeneca Reports LYNPARZA Received Positive EU CHMP Opinion In Platinum-Sensitive Relapsed Ovarian Cancer",mildly bullish
2018-03-20 15:29:00+00:00,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,neutral
2018-03-26 16:01:00+00:00,"Stocks That Made New 52-Wk Lows Today Include: Charter Comms., Vornado Realty, Colgate-Palmolive, Merck, Hasbro, Ventas, Dentsply Sirona, Johnson Controls, Goodyear Tire, Clorox, GE, Kinder Morgan, Comcast, DISH Network, Stericycle and Patterson Cos.",mildly bearish
2018-04-03 16:15:00+00:00,"Stocks That Made New 52-Wk Lows Today Include: Incyte, Merck, Mallinckrodt, Celgene, Cerner, Willams Cos., AMD, Albemarle, Kinder Morgan, Western Union, Walgreens, Kraft Heinz, Nielsen, and Alliance Data Systems",mildly bearish
2018-04-09 10:46:00+00:00,Merck Reports its KEYTRUDA Monotherapey Met its Primary Endpoint in the Phase 3 KEYNOTE-042 Study,mildly bullish
2018-04-10 08:21:00+00:00,40 Biggest Movers From Yesterday,neutral
2018-04-15 17:53:00+00:00,"Merck Announces KEYTRUDA Reduced Risk of Disease Recurrence or Death by More than 40% vs Placebo as Adjuvant Therapy in Resected, High-Risk Stage III Melanoma",mildly bullish
2018-05-01 10:47:00+00:00,"Merck Reports Q1 Adj. EPS $1.05 Beats $1.00 Est., Sales $10.04B Misses $10.10B Est.",mildly bullish
2018-05-01 12:24:00+00:00,Benzinga Pro's 5 Stocks To Watch Today,neutral
2018-05-03 10:58:00+00:00,Merck Says Phase 3 KEYNOTE-407 Met A Pre-Specified Secondary Endpoint Related To Overall Response Rate In A Cohort Of Participants At An Interim Analysis,mildly bullish
2018-05-14 10:59:00+00:00,"WHO Says 39 Cases Of Ebola Reported In Congo Outbreak So Far, Including 19 Deaths",neutral
2018-05-17 11:28:00+00:00,WHO Says Will Convene Emergency Meeting On Fri. To Determine If Ebola Outbreak In Congo Is A Public Emergency Of Int'l. Concern,neutral
2018-05-25 13:19:00+00:00,"Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended",neutral
2018-06-03 11:47:00+00:00,Merck Announces KEYTRUDA Monotherapy Significantly Improved Overall Survival in KEYNOTE-042 Study as First-Line Treatment for Locally Advanced or Metastatic NSCLC Patients Whose Tumors Expressed PD-L1 (TPS ≥1%),mildly bullish
2018-06-03 11:48:00+00:00,Merck Announces KEYTRUDA Plus Chemotherapy Significantly Improved Overall Survival in First-Line Treatment of Metastatic Squamous NSCLC in Phase 3 KEYNOTE-407 Study,mildly bullish
2018-06-04 21:01:00+00:00,Merck and Astrazeneca Pres Relase Announces LYNPARZA In Combo With Abiraterone Delayed Metastatic Prostate Cancer Disease Progression,mildly bullish
2018-06-15 16:23:00+00:00,30 Stocks Moving In Friday's Mid-Day Session,neutral
2018-06-27 08:01:00+00:00,"AstraZeneca, Merck Announce LYNPARZA S Met Primary Endpoint of Progression-Free Survival in Women with BRCA-Mutated Advanced Ovarian Cancer and Showed a Safety Profile Consistent with Previous Trials",mildly bullish
2018-06-27 21:01:00+00:00,Merck Reports Study Results From Heat-Stable Formulation Of Carbetocin For Prevention Of Excessive Bleeding After Childbirth: Showed Clinical Non-Inferiority To Oxycontin For Primary Outcome Of Greater Than Equal To 500 ml Of Blood Loss,mildly bullish
2018-07-02 10:46:00+00:00,Merck's Supplemental Biologics License for KEYTRUDA in Combination with Chemotherapy is Granted Priority Review by the FDA,mildly bullish
2018-07-11 10:56:00+00:00,FDA Grants Merck Priority Review To Co.'s  Supplemental Biologics License Application For Its KEYTRUDA Hepatocellular Carcinoma Therapy,mildly bullish
2018-07-19 18:48:00+00:00,"UPDATE: Merck, Responding To Responsibility On Drug Pricing, Says 'We are also lowering our price on ZEPATIER by 60 percent and several other medicines by 10 percent to reduce out-of-pocket costs for patients across the country'",mildly bullish
2018-07-23 18:42:00+00:00,Morgan Stanley: Newly Public Neon Therapeutics Has Outperformance Potential,mildly bullish
2018-07-25 12:41:00+00:00,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",mildly bullish
2018-07-27 08:56:00+00:00,"12 Stocks To Watch For July 27, 2018",neutral
2018-07-27 11:31:00+00:00,Endo Int'l. Reports Par Pharma Has Begun Shipping Authorized Generic Version Of Merck's INVANZ,neutral
2018-08-07 15:27:00+00:00,"Stocks Which Set New 52-Week High Yesterday, August 6th",neutral
2018-08-09 08:02:00+00:00,Perrigo Announces Rx-To-OTC Switch Licensing For Nasonex,neutral
2018-08-17 12:01:00+00:00,Eisai And Merck Announce FDA Approval Of LENVIMA,mildly bullish
2018-08-22 13:06:00+00:00,"Stocks Which Set New 52-Week High Yesterday, August 21st",neutral
2018-08-30 12:02:00+00:00,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",neutral
2018-09-05 11:56:00+00:00,"Ebola-Related Stocks Unaffected Amid Earlier Report Officials In Congo Announced The First Ebola Case In A Major Eastern City, Butembo",neutral
2018-09-10 10:45:00+00:00,European Commission Approves Merck's KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC,mildly bullish
2018-09-10 11:02:00+00:00,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,mildly bullish
2018-10-11 13:57:00+00:00,"Credit Suisse Maintains Outperform on Merck & Co, Raises Price Target to $81",mildly bullish
2018-10-12 12:26:00+00:00,"Barclays Maintains Overweight on Merck & Co, Raises Price Target to $78",mildly bullish
2018-10-20 20:54:00+00:00,ImmunoGen Presents Encouraging Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO 2018,mildly bullish
2018-10-20 20:57:00+00:00,Merck Announces KEYTRUDA Showed a Complete Response Rate of Nearly 40% in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to Standard of Care at ESMO 2018,mildly bullish
2018-10-21 19:40:00+00:00,"AstraZeneca, Merck Announce Solo-1 Phase III Trial Demonstrates Lynparza Maintenance Therapy Cut the Risk of Disease Progression or Death by 70% in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer at ESMO",mildly bullish
2018-10-25 10:46:00+00:00,"Merck & Co Q3 EPS $1.19 Beats $1.14 Estimate, Sales $10.794B Miss $10.88B Estimate",mildly bearish
2018-10-27 14:23:00+00:00,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",neutral
2018-10-30 12:00:00+00:00,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",neutral
2018-11-08 15:52:00+00:00,"Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 7, 2018",neutral
2018-11-15 14:02:00+00:00,"NewLink Genetics Announces Merck Has Begun Rolling Submission Of Licensure Application For Ebola vaccine V920 To U.S. FDA; In 2014, Co. Entered Ito License Agreement With Merck To Develop, Manufacture And Commercialize Ebola Vaccine",mildly bullish
2018-11-28 21:30:00+00:00,Merck Receives European Commission Approval For DELSTRIGO As Part OF An HIV-1 Treatment Regimen,mildly bullish
2018-12-04 12:59:00+00:00,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",neutral
2018-12-04 14:20:00+00:00,"Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018",neutral
2018-12-04 15:24:00+00:00,"Ahead Of Mid-Week Pause, Investors Fret Over Trade Pact Details",neutral
2018-12-11 13:22:00+00:00,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",neutral
2018-12-12 15:31:00+00:00,Merck and Instituto Butantan Announce Collaboration Agreement To Develop Dengue Infections Vaccine; Instituto Butantan To Receive $26M Upfront And Is Eligible For Up To $75M In Milestones,mildly bullish
2018-12-17 11:33:00+00:00,Merck's KEYTRUDA as Adjuvant Therapy for Adults with Resected Stage III Melanoma Approved by the European Commission,mildly bullish
2018-12-19 21:14:00+00:00,FDA Approves Merck's KEYTRUDA For Treatment Of Recurrent Locally Advanced Or Metastatic Merkel Cell Carcinoma,mildly bullish
2019-01-14 22:02:00+00:00,"Merck Reports KEYTRUDA Reduced Risk Of Death By 31% Vs Chemotherapy In Previously-Treated Patients With Advanced Esophageal, Esophagogastric Junction Carcinoma Whose Tumors Expressed PD-L1",mildly bullish
2019-02-01 09:46:00+00:00,"12 Stocks To Watch For February 1, 2019",neutral
2019-02-01 14:10:00+00:00,"The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of  Titan's Opioid Disorder Treatment Implant",mildly bullish
2019-02-05 11:49:00+00:00,FDA Accepts For Review New Drug Application For Merck's Investigational Combination Of Imipenem/Cilastatin And Relebactam; Acceps Supplemental NDA For ZERBAXA,mildly bullish
2019-02-05 13:39:00+00:00,Codexis shares are trading higher after the company reported a multi-year agreement with Merck to perform technology upgrades.,mildly bullish
2019-02-21 13:09:00+00:00,31 Stocks Moving In Thursday's Pre-Market Session,neutral
2019-02-22 10:02:00+00:00,65 Biggest Movers From Yesterday,neutral
2019-02-25 13:56:00+00:00,"Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired",mildly bullish
2019-02-26 09:01:00+00:00,"AstraZeneca, Merck Announce Phase III POLO Trial Met its Primary Endpoint of Progression-free Survival",mildly bullish
2019-03-22 12:16:00+00:00,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",neutral
2019-03-23 16:20:00+00:00,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs",neutral
2019-03-29 17:55:00+00:00,Congo Health Ministry Says Has Recorded 15 New Confirmed Cases Of Ebola,neutral
2019-04-11 16:33:00+00:00,NYC Mandates Measles Vaccinations; Merck Is The Exclusive Manufacturer,mildly bullish
2019-04-18 14:51:00+00:00,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,mildly bearish
2019-04-22 10:47:00+00:00,Merck's KEYTRUDA in Combination with Inlyta Approved by the FDA as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma,mildly bullish
2019-05-02 12:06:00+00:00,"UBS Maintains Buy on Merck & Company, Inc. Common Stock (new), Raises Price Target to $88",mildly bullish
2019-05-16 18:50:00+00:00,5 ASCO Abstracts That Moved Stocks,neutral
2019-05-20 18:28:00+00:00,"Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To Sidelines",mildly bearish
2019-05-22 16:38:00+00:00,Merck's Keytruda Vs. Bristol-Myers Squibb's Opdivo In Q1 And Beyond,neutral
2019-05-31 10:46:00+00:00,Merck Reports KEYTRUDA Showed Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at Final Analysis of Pivotal Phase 3 KEYNOTE-048 Trial,mildly bullish
2019-06-01 11:36:00+00:00,Merck Announces Five-Year Survival Data for KEYTRUDA in Advanced Non-Small Cell Lung Cancer from First KEYNOTE Trial at #ASCO19,mildly bullish
2019-06-03 20:15:00+00:00,Merck Reports LYNPARZA Phase 3 SOLO3 Trial Showed 72% Objective Response Rate in Patients with Platinum-Sensitive Relapsed Germline BRCA-mutated Advanced Ovarian Cancer Compared to 51% of Patients Receiving Chemotherapy,mildly bullish
2019-06-04 11:45:00+00:00,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer",neutral
2019-06-04 17:07:00+00:00,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,mildly bullish
2019-06-11 13:14:00+00:00,"FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer",mildly bullish
2019-06-18 08:27:00+00:00,"AstraZeneca, Merck Announce Lynparza Approved in the EU for 1st-line Maintenance Treatment Of BRCA-mutated Advanced Ovarian Cancer",mildly bullish
2019-06-19 08:58:00+00:00,"AstraZeneca,Merck Announce Lynparza Approved in Japan for 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer",mildly bullish
2019-06-19 19:43:00+00:00,Report: Merck Searching Internally For Next CEO,neutral
2019-06-22 19:07:00+00:00,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",neutral
2019-07-27 18:32:00+00:00,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",neutral
2019-07-29 11:02:00+00:00,Merck's KEYTRUDA in Combination with Chemotherapy Met One of the Dual Primary Endpoints in Pivotal Phase 3 KEYNOTE-522,mildly bullish
2019-07-31 12:18:00+00:00,SELLAS Advances Galinpepimut-S (GPS) In Combination With KEYTRUDA Program With Dosing Of First Patient In Phase 1/2 Basket Study,mildly bullish
2019-08-14 08:40:00+00:00,Lynparza Phase Iii Paola-1 Trial Met Primary Endpoint as 1st-line Maintenance Treatment With Bevacizumab for Advanced Ovarian Cancer,mildly bullish
2019-08-29 18:57:00+00:00,Uganda Confirms Another Case Of Ebola - A 9-Year Old Girl Who Traveled Democratic Republic Of Congo,neutral
2019-08-30 08:04:00+00:00,"Deaths from E. Congo Ebola Outbreak Top 2,000; Cases Top 3,000",mildly bearish
2019-09-10 14:30:00+00:00,Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed bill would set US drug prices based on prices in other wealthy countries.,mildly bearish
2019-09-17 10:45:00+00:00,"Merck Reports FDA Accepted Biologics License Application, Granted Priority Review For V920 For Ebola Zaire Virus",mildly bullish
2019-09-17 15:56:00+00:00,FDA Says Granted Accelerated Approval To Lenvima In Combo With Keytruda For Treatment Of Patients With Advanced Endometrial Carcinoma,mildly bullish
2019-09-20 11:46:00+00:00,"The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering",mildly bullish
2019-09-30 10:47:00+00:00,Merck's Pivotal RESTORE-IMI 2 Phase 3 Study of RECARBRIO Met its Primary Endpoint,mildly bullish
2019-10-03 15:45:00+00:00,What's Behind PDS Biotech's Rally?,neutral
2019-10-03 19:49:00+00:00,Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar,mildly bullish
2019-10-08 15:08:00+00:00,"Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks",mildly bearish
2019-10-11 15:19:00+00:00,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,mildly bullish
2019-10-17 11:21:00+00:00,"Bank of America Reinstates Neutral on Merck & Co, Announces $90 Price Target",neutral
2019-10-18 11:00:00+00:00,"Merck Reports Positive EU CHMP Opinion For 2 New Regimens Of KEYTRUDA As First-Line Treatment For Metastatic Or Unresectable Recurrent Head, Neck Squamous Cell Carcinoma",mildly bullish
2019-10-18 18:48:00+00:00,"WHO Says Ebola Concentrated In Congo Mining Area, Still An Emergency",mildly bearish
2019-10-28 15:56:00+00:00,More Earnings And A Fed Decision In Week Four Of The WeTrader Competition,neutral
2019-10-29 08:57:00+00:00,"Earnings Scheduled For October 29, 2019",neutral
2019-10-29 11:25:00+00:00,Merck & Co shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS and sales guidance above analyst estimates.,mildly bullish
2019-10-29 12:33:00+00:00,28 Healthcare Stocks Moving In Tuesday's Pre-Market Session,neutral
2019-11-01 21:15:00+00:00,WeTrader Competition: Round Four Wrap-up,neutral
2019-11-06 16:20:00+00:00,AstraZeneca Named The Most Innovative Global Pharma Company,neutral
2019-11-13 13:12:00+00:00,"Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $95",mildly bullish
2019-11-15 11:45:00+00:00,Merck Reports Its Animal Health Unit Announced US Approval Of BRAVECTO PLUS,mildly bullish
2019-11-20 11:46:00+00:00,European Commission Approves Two New Regimens Of Merck's KEYTRUDA As First-Line Treatment For Metastatic Or Unresectable Recurrent Head And Neck Squamous Cell Carcinoma,mildly bullish
2019-11-27 12:26:00+00:00,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",neutral
2019-11-27 15:14:00+00:00,Stocks That Hit 52-Week Highs On Wednesday,neutral
2019-11-27 15:14:00+00:00,Stocks That Hit 52-Week Highs On Wednesday,neutral
2019-12-03 12:59:00+00:00,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",neutral
2019-12-04 15:30:00+00:00,Stocks That Hit 52-Week Highs On Wednesday,neutral
2019-12-05 10:24:00+00:00,"AstraZeneca, Merck Announce Lynparza Approved in China as a 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer",mildly bullish
2019-12-09 12:49:00+00:00,20 Stocks Moving In Monday's Pre-Market Session,neutral
2019-12-11 12:21:00+00:00,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",mildly bearish
2019-12-12 17:03:00+00:00,Traders Circulating Materials From Merck's Keytruda Presentation At ESMO,neutral
2019-12-20 11:46:00+00:00,"Merck Reports KEYTRUDA Approved In Japan For 3 New First-Line Indications Across Advanced Renal Cell Carcinoma, Recurrent or Distant Metastatic Head and Neck Cancer",mildly bullish
2019-12-27 17:23:00+00:00,Merck & Co Option Alert: Jun 19 $92.5 Calls Sweep (49) above Ask!: 4764 @ $4.107 vs 5293 OI; Earnings 1/31 Before Open [est] Ref=$91.46,mildly bullish
2019-12-29 23:38:00+00:00,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus",neutral
2019-12-30 10:27:00+00:00,AstraZeneca Says FDA Approved Lynparza for Pancreatic Cancer,mildly bullish
2019-12-30 16:41:00+00:00,Merck-AstraZeneca's Lynparza Snags FDA Nod For Pancreatic Cancer,mildly bullish
2020-01-09 13:39:00+00:00,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results",mildly bullish
2020-01-10 17:55:00+00:00,"'California Gov. Gavin Newsom wants the state to become the first to create its own generic drug label, an attempt to create more competition and bring down prices.' -Axios, From Earlier",neutral
2020-01-23 14:54:00+00:00,"UBS Maintains Buy on Merck & Co, Raises Price Target to $99",mildly bullish
2020-01-24 12:43:00+00:00,"The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study",mildly bearish
2020-01-24 16:40:00+00:00,"Shares of several companies in the healthcare and pharmaceutical space are trading lower, not currently seeing sector-specific news. NOTE: The global spread of the Wuhan coronavirus has caused equities across to sell off.",mildly bearish
2020-01-27 11:51:00+00:00,Merck's DIFICID Receives FDA Approval to Treat Clostridioides in Children Aged Six Months and Older,mildly bullish
2020-01-27 12:06:00+00:00,A Peek Into The Markets: US Stock Futures Down; Dow Futures Tumble Over 400 Points,strongly bearish
2020-01-28 14:39:00+00:00,Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later,mildly bullish
2020-02-02 18:04:00+00:00,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",neutral
2020-02-03 18:30:00+00:00,Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates,neutral
2020-02-05 11:48:00+00:00,"Merck & Co Q4 Adj. EPS $1.16 Beats $1.15 Estimate, Sales $11.87B Miss $11.98B Estimate",mildly bearish
2020-02-05 15:00:00+00:00,"Earnings Bonanza: Results Keep Pouring In, With Investors Looking Over Merck, Disney",neutral
2020-02-08 16:45:00+00:00,"Barron's Picks And Pans: GM, Kraft Heinz, Tesla, Under Armour And More",neutral
2020-02-11 12:23:00+00:00,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",neutral
2020-02-19 12:21:00+00:00,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",mildly bearish
2020-02-20 16:35:00+00:00,Why Merck Has Had Underwhelming Start To 2020,mildly bearish
2020-02-23 23:38:00+00:00,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,neutral
2020-03-02 11:33:00+00:00,Merck's Phase 3 KEYNOTE-204 Trial of KEYTRUDA Met One of its Primary Endpoints,mildly bullish
2020-03-11 11:15:00+00:00,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,mildly bearish
2020-03-12 11:37:00+00:00,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",neutral
2020-03-24 12:42:00+00:00,"Argus Research Maintains Buy on Merck & Co, Lowers Price Target to $95",mildly bullish
2020-03-30 14:17:00+00:00,Shares of several healthcare companies are trading higher as the market rebounds on extended measures to help curb the coronavirus. NOTE: The sector could also be trading higher due to increased demand for medical products amid the coronavirus outbreak.,mildly bullish
2020-04-13 10:57:00+00:00,"AstraZeneca and Merck Announce Approval of KOSELUGO for Pediatric Patients Two Years and Older With Neurofibromatosis Type 1 and Symptomatic, Inoperable Plexiform Neurofibromas",mildly bullish
2020-04-16 10:08:00+00:00,"Next 45 Days Will Be 'Most Critical Period' For US, Says Alan Lancz Who Predicted 1987 and 2008 Crises",neutral
2020-04-23 15:27:00+00:00,Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices.,mildly bullish
2020-04-27 10:50:00+00:00,Merck and Institute for Systems Biology Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers for Coronavirus,mildly bullish
2020-04-28 12:40:00+00:00,Merck shares are trading lower after the company issued FY20 guidance below consensus estimates.,mildly bearish
2020-04-28 18:48:00+00:00,A CURE For The Common Earnings Play,neutral
2020-04-29 15:04:00+00:00,"Merck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance Cut",mildly bullish
2020-05-03 13:25:00+00:00,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,mildly bullish
2020-05-13 21:06:00+00:00,Merck Reports KEYTRUDA Plus Chemo Showed Statistically Significant Improvement In Progression-Free Survival vs Chemo In Certain Patients With Metastatic Triple-Negative Breast Cancer,mildly bullish
2020-05-21 17:18:00+00:00,51 Stocks Moving In Thursday's Mid-Day Session,neutral
2020-05-21 18:30:00+00:00,Mid-Afternoon Market Update: Dow Falls 50 Points; L Brands Shares Spike Higher,neutral
2020-05-22 09:26:00+00:00,64 Biggest Movers From Yesterday,neutral
2020-05-22 17:50:00+00:00,"US Says Will Test Experimental Coronavirus Vaccines In 100,000+ People, Health Official Says Oxford Vaccine May Be Tested ""Side By Side"" With Moderna's Starting In July",mildly bullish
2020-05-26 12:13:00+00:00,"Benzinga Pro's Top 5 Stocks To Watch For Tues., May 26, 2020: NVAX, EWJ, SNY, SOXX, MRK",neutral
2020-05-26 14:48:00+00:00,"Merck's Coronavirus Plan Of Attack: 2 Partnerships, M&A Deal Aimed At Treatment, Vaccine Development",mildly bullish
2020-05-30 13:25:00+00:00,"The Week Ahead In Biotech: ASCO, Menlo And Merck FDA Decisions, IPOs In The Spotlight",neutral
2020-06-01 12:39:00+00:00,'New Ebola epidemic' in northwest DR Congo: health ministry' -AFP,mildly bearish
2020-06-11 14:22:00+00:00,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",mildly bearish
